Your browser doesn't support javascript.
loading
FACTORS INFLUENCING ANTI-POLYRIBOSYLRIBITOL PHOSPHATE TITRES IN YOUNG NIGERIAN CHILDREN PRIMED WITH DTWP-HEPB-HIB VACCINE.
Ozhe, Sunday Ikukpla'si; Shwe, David Danjuma; Yilgwan, Christopher Sabo; Isaac, Johnson Ajeh; Ebisike, Kelechi Joseph; Ocheke, Isaac Ejembi.
Affiliation
  • Ozhe SI; Department of Paediatrics, Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State.
  • Shwe DD; Department of Paediatrics, University of Jos/Jos University Teaching Hospital, Jos, Plateau State.
  • Yilgwan CS; Department of Paediatrics, University of Jos/Jos University Teaching Hospital, Jos, Plateau State.
  • Isaac JA; Department of Pharmaceutical and Raw Materials Development, National Institute for Pharmaceutical Research and Development, Abuja.
  • Ebisike KJ; Department of Paediatrics, Federal Teaching Hospital/Gombe State University, Gombe, Gombe State.
  • Ocheke IE; Department of Paediatrics, University of Jos/Jos University Teaching Hospital, Jos, Plateau State.
West Afr J Med ; 40(12 Suppl 1): S35, 2023 Dec 04.
Article in En | MEDLINE | ID: mdl-38070169
ABSTRACT

Introduction:

Recent research suggests that variation in vaccine-induced immune responses is influenced by genetic, nutritional, environmental, and vaccine-related factors, with significant vaccine design and programmatic policy implications. Haemophilus influenzae type b (Hib) Conjugate Vaccine (HCV) stimulates the production of antiPolyribosylribitol phosphate (anti-PRP) antibodies, which confer long-term protection against invasive Hib disease and nasopharyngeal colonization by Hib at titre levels ≥1µg/mL and ≥5µg/mL respectively. This study investigated the influence of these factors on the protective anti-PRP levels in children aged 6-23 months in Obi L.G.A. of Nasarawa State, Nigeria.

Methods:

The study was a cross-sectional, two-stage household-level cluster survey involving 267 children who had completed the E.P.I. schedule of HCV-containing DTwP-HepB-Hib. Validated questionnaires were used for enrolment and relevant clinical and laboratory evaluations including anti-PRP, ABO/Rhesus antigens, and Haemoglobin genotype assays were conducted. Regression analyses were performed using Stata to explore the correlation between sociodemographic/vaccine-related factors, nutritional status, genotype, ABO/Rhesus antigens, and protective anti-PRP titres.

Results:

Bivariate analysis showed that age, breastfeeding practice, household size/under-five number, nutritional, socioeconomic, Measles/Yellow fever vaccination, and Rhesus statuses were significantly associated with anti-PRP titre. However, multivariate analysis revealed that age between 6-11 months (AOR=3.12,95%CI=1.15-8.50), households with less than three under-fives (AOR=2.33,95%CI=1.14-4.78), middle socioeconomic class (AOR=3.15,95%CI=1.42-6.98), wasting (AOR=2.27,95%CI=1.23-4.22) and Measles/Yellow fever vaccination (AOR=2.90,95%CI=1.38-6.07) were significantly correlated with protective anti-PRP titres.

Conclusion:

Results indicate that the family and socioeconomic milieu influence anti-PRP titre, and Measles/Yellow fever vaccines may have a beneficial non-specific effect on HCV-induced seroprotection in Nigerian children.
Subject(s)
Key words
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Yellow Fever / Hepatitis C / Haemophilus Vaccines / Measles Limits: Child / Humans / Infant Language: En Journal: West Afr J Med Year: 2023 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Yellow Fever / Hepatitis C / Haemophilus Vaccines / Measles Limits: Child / Humans / Infant Language: En Journal: West Afr J Med Year: 2023 Document type: Article